Company Filing History:
4 out of 52 
1 out of 114 
Years Active: 2007-2025
Title: Mary T Wrin - A Pioneer in Viral Research
Introduction
Mary T Wrin, an innovative inventor based in Fremont, CA, has made significant contributions to the field of virology. With a total of 4 patents to her name, her work primarily focuses on methods for evaluating viral receptor and co-receptor usage, which are crucial in understanding and combating viral infections.
Latest Patents
Mary's latest patents highlight her expertise in the intersection of virology and therapeutic development. One notable invention is the method for evaluating viral receptor/co-receptor usage and inhibitors of virus entry using recombinant virus assays. This innovative approach allows for the identification of compounds that may inhibit the entry of viruses into host cells.
Her second major invention, aimed at determining the presence of antibodies blocking viral infection, outlines a detailed process for assessing the efficacy of therapeutic compounds. This method involves obtaining nucleic acids from infected patients and co-transfecting them into host cells, allowing for the evaluation of viral infectivity in the presence of potential inhibitors. Both inventions stand to enhance the understanding of viral mechanisms and pave the way for effective treatments.
Career Highlights
Mary T Wrin is currently associated with Monogram Biosciences, Inc., where she applies her expertise in virology to advance research and development. Her work has been critical in helping to address various viral challenges, making her a prominent figure in the field.
Collaborations
Throughout her career, Mary has collaborated with accomplished professionals such as Christos J Petropoulos and Neil T Parkin. These partnerships have enriched her research, allowing for a robust exchange of ideas and fostering innovative solutions in viral studies.
Conclusion
Mary T Wrin exemplifies the spirit of innovation in scientific research. Her contributions in developing methods for understanding viral mechanisms and potential treatments underscore her commitment to advancing public health. Her work continues to inspire future generations of researchers aiming to tackle the challenges posed by viral infections.